|
Acquisition of Biodynamics Research Limited |
|
|
|
Further expansion for Quotient bioresearch in drug development services
Acquisition of Biodynamics builds capacity and service offering
Newmarket, United Kingdom, February 11, 2008 – Quotient BioResearch Limited ("Quotient BioResearch"), the leading European provider of analytical and safety evaluation services and products for bioscience and sport, is pleased to announce that it has acquired BioDynamics Research Limited ("BioDynamics").
|
|
Read more...
|
|
|
Appointment of Gordon Cameron as Chief Financial Officer |
|
|
|
Newmarket, United Kingdom, September 14, 2007 – Quotient BioResearch Limited, the provider of analytical and safety evaluation services and products to the healthcare, pharmaceutical and biotechnology industries, is pleased to announce the appointment of Gordon Cameron, OBE as its new Chief Financial Officer.
|
|
Read more...
|
|
|
Quotient BioResearch Limited |
|
|
|
Newmarket, United Kingdom, September 14, 2007 – Quotient BioResearch Limited, the provider of analytical and safety evaluation services and products to the healthcare, pharmaceutical and biotechnology industries, is pleased to announce that it has acquired 100% of the share capital of GRM Holdings Limited which includes G.R. Micro Ltd. ("GRM") and G.R. Micro Environmental Healthcare Ltd. ("GRM-EH").
|
|
Read more...
|
|
|
G.R. Micro Environmental Healthcare Ltd |
|
|
|
We are pleased to inform that our Environmental Department has grown to form its own entity of its own right. From the beginnings of G.R. Micro Ltd we have always sought to provide our clients with a portfolio of expertise. Our Managing Director of our Environmental Department - Mark Hichens, first started...
|
|
Read more...
|
|
|
The Queen's Award For Enterprise |
|
|
|
G.R. Micro Ltd was established in 1983 by two leading NHS Consultant Medical Microbiologists - Dr Reuben GrĪneberg MD and Dr Geoff Ridgway MD - to offer a range of microbiological services to the pharmaceutical and healthcare industries.
|
|
Read more...
|
|
|
|